mRNA vaccines use the body's own machinery to make antigenic protein rather than injecting the antigen directly into the body. (Image Credits: Pixabay) Gennova Biopharmaceuticals Ltd. on Tuesday ...

Pune-based Gennova Biopharmaceuticals Ltd will develop a self-amplifying mRNA vaccine candidate against the deadly Nipah virus. The critical initiative is supported by an expanded partnership with the ...

The clinical trials are set to begin in India, where past Nipah outbreaks have been recorded. Nipah virus, a highly lethal pathogen belonging to the Paramyxovirus family, has caused multiple outbreaks ...